--- title: 'AI Research Scientist III at 1910' canonical: 'https://feeny.ai/job/ai-research-scientist-iii-1910-boston-fn1a8zqpnc42' type: 'job' last_seen: '2026-09-11' --- # AI Research Scientist III at 1910 - **Company:** 1910 - **Location:** Boston, MA - **Posted:** 2026-01-26 - **Last confirmed live:** 2026-09-11 - **Apply:** https://job-boards.greenhouse.io/1910genetics/jobs/5096351008 ## Job description Company Overview We are the only AI-native biotech, pioneering small and large molecule therapeutics discovery by integrating massive multimodal data, frontier AI models, and high-throughput lab automation into an infrastructure for AI-enabled drug discovery. We hire top 1% talent to join our interdisciplinary team of scientists, engineers, researchers, operators, innovators, drug developers, business professionals, and technologists. Join us to build the world’s first AI infrastructure for tech-enabled drug discovery and to deliver a pipeline of diverse drug modalities for all major disease areas. As an AI Research Scientist III at 1910 you will be expected to roll up your sleeves as an Individual Contributor (IC) by keeping up with relevant scientific literature, prototyping promising methods, and contributing to our active drug design campaigns by applying 1910’s productionized AI/ML models. ## Role Description - Propose and prototype AI and Machine Learning solutions that address use cases in 1910’s design pipeline - Independently apply productized AI and Machine Learning models to advance 1910’s active drug design campaigns - Independently write and publish peer reviewed scientific articles  and mentor junior AI Researchers with their work - Periodically presenting recent AI research at internal journal clubs - Work cross-functionally with scientific colleagues, being a subject matter expert in how AI and Machine Learning can be used to answer cheminformatics and bioinformatics questions - Keep up-to-date on cutting-edge research in the AI for drug discovery space - Manage junior AI Research Scientists including having weekly 1:1s, and regular performance reviews ## Qualifications - PhD in a relevant discipline (Computer Science, Biology, Chemistry, etc.) - 3+ years of relevant industry experience (AI, Drug Discovery, etc.) - A strong understanding of statistics and classical machine learning methods (SVM, RF, etc.) - Industry experience training and deploying cutting edge deep learning methods (Transformers, Graph Neural Networks, etc.) - Wet lab validation of at least 2 AI-driven drug discovery initiatives - Demonstrated experience writing clean, maintainable, production-quality Python code, with examples available in code repositories - Familiarity with MLOps and DevOps best practices - Exposure to distributed computing (Microsoft Azure, HPC Cluster, etc.) - Strong track record of publications of individual research in top-tier AI journals and conferences - Ability to demonstrate business value related to developed AI and Machine Learning solutions in biology and medicinal chemistry related to your modeling efforts - Ability to work effectively in a fast-paced startup environment with evolving projects and shifting priorities driven by business needs - Excellent written and verbal communication skills, including the ability to create clear documentation for roadmaps, proposals, and related materials Nice to Haves - Past experience managing junior AI Research Scientists #LI-Onsite Diversity and Inclusion (1910’s Promise) At 1910, we believe that a diverse, equitable, and inclusive workplace furthers relevance, resilience, and longevity. We encourage people from all backgrounds, ages, abilities, and experiences to apply. 1910 is proud to be an equal-opportunity workplace and is an affirmative action employer. We are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity, or Veteran status. If, due to a disability, you need an accommodation during any part of the interview process, please let your recruiter know. While 1910 supports visa sponsorship, sponsorship opportunities may be limited to certain roles and skills. ## Benefits and Perks - Competitive compensation package - Above market benefits - Generous vacation and parental leave - Super cool team building activities - Great colleagues ## About 1910 ## Company Overview - **One-liner**: 1910 is an AI-native biotechnology company building the infrastructure layer for tech-enabled drug discovery, using a multimodal AI platform integrated with laboratory automation to design small molecule and protein therapeutics. - **Entity Type**: Private (Series A - III) - **Headquarters**: Boston, Massachusetts, United States - **Founded**: 2018 - **Founders**: Jen Asher, Ph.D. ## Core Business - **Primary Industries**: AI-driven Drug Discovery, Biotechnology, Computational Chemistry - **Target Customers**: Pharmaceutical and biotech companies (partnerships), as well as an internal pipeline for drug development (B2B and internal R&D) - **Mission/Purpose**: “We exist to alleviate human suffering” and “make undruggable targets a thing of the past.” ## Products & Services - **ITO™ Platform**: A first-of-its-kind Multimodal AI Platform for Modality Agnostic Drug Discovery. It integrates three proprietary data streams (computational, wet lab proxy biological, and wet lab ground truth biological) with frontier AI models and high-throughput lab automation to identify novel disease targets and design both small molecule and large molecule (protein) therapeutics. - **ELVIS™ and ROSALYND™ Platforms**: AI-powered platforms within the ITO ecosystem specifically for small molecule drug design and protein therapeutic design. - **CANDID-CNS™**: An AI model (attentive graph neural network) for predicting blood-brain barrier (BBB) penetration, especially for Beyond Rule of 5 (bRo5) molecules and stereoisomers. It was published in the Journal of Chemical Information and Modeling (JCIM) in December 2025 and outperforms industry standards like Pfizer’s CNS MPO. - **Internal Pipeline**: Includes programs in neurological, autoimmune diseases, and cancer, including a non-opioid chronic pain candidate (1910-102) partially funded by the NIH HEAL Initiative. ## Market Standing - **Valuation**: Not publicly disclosed - **Total Funding**: $36.65 million (Series A - III) [cbinsights.com](https://www.cbinsights.com/company/1910-genetics) - **Notable Investors**: Accenture Ventures, FoundersX Ventures, Tenacity Venture Capital, Pioneer Fund, Soma Capital, and 14 others [cbinsights.com](https://www.cbinsights.com/company/1910-genetics) - **Growth Signals**: - Published CANDID-CNS™ in a peer-reviewed ACS journal (JCIM) in December 2025, establishing a scientific milestone for bRo5 and stereochemistry prediction [globenewswire.com](https://www.globenewswire.com/). - Announced a collaboration with Accenture to help biopharma companies transform drug discovery with AI [1910genetics.com](https://www.1910genetics.com/). - Active NIH-funded program (HEAL Initiative) for non-opioid chronic pain. - Filed at least one patent (substituted pyrimidine compounds as TYK2 inhibitors) [cbinsights.com](https://www.cbinsights.com/company/1910-genetics). ## Competitive Advantages - **Multimodal AI Platform**: 1910 is unique for being “modality agnostic” — capable of designing both small molecule drugs and large molecule (protein) therapeutics using a single integrated AI platform. This includes ~100 AI models (including CANDID-CNS™) within the ITO platform. - **Proprietary Data Flywheel**: The company generates three proprietary data streams (computational, wet lab proxy, wet lab ground truth) which are fed back into the AI models, creating a continuous learning loop that competitors may lack. - **Scientific Credibility**: Published in top-tier journals (JCIM, ACS) and backed by experienced scientists from Novartis, Eli Lilly, and Pfizer. - **Focus on Undruggable Targets**: Their explicit mission is to tackle targets previously considered undruggable, especially in CNS and autoimmune diseases. ## Strategic Focus - **Current Priorities**: Advancing the internal pipeline (neurological, autoimmune, cancer) while expanding partnerships with pharma and tech companies. Specific focus on CNS drug discovery through the CANDID-CNS™ model and the 1910-102 chronic pain program. - **Growth Direction**: Scaling the ITO platform and its AI models to handle more complex targets, and increasing collaborations with major pharmaceutical partners. The company is also actively hiring to expand its AI and computational chemistry teams. ## Why Work Here - **Culture & Mission**: The company explicitly states “We exist to alleviate human suffering.” The culture emphasizes impact, urgency, integrity, teamwork, ownership, and grit. - **Interdisciplinary Team**: Composed of Machine Learning Engineers, Medicinal Chemists, Computational Chemists, Assay Biologists, and Business Strategists — offering a highly collaborative, cross-functional environment. - **Workplace**: Based in Boston, MA (451 D Street, Suite 905). The roles listed (AI Research Scientists, Computational Theoretical Chemists) suggest a need for on-site or hybrid presence for wet lab integration, though specific remote/hybrid policies are not stated. - **Leadership**: Founder & CEO Jen Asher holds a Ph.D., with experience at Bain & Company, Novartis, Eli Lilly, and Harvard/Tufts. The Head of AI Research (Brandon Moore) has a Ph.D. from Vanderbilt with a background in neuroscience and ML. - **Growth Stage**: Operating at Series A-III with a proven scientific track record, the company offers a high-growth environment with the opportunity to work on cutting-edge AI biotech problems that directly impact human health. - **Open Roles**: As of the latest data, open positions include AI Research Scientist (multiple levels) and Computational Theoretical Chemist roles based in Boston, MA [greenhouse.io](https://job-boards.greenhouse.io/1910genetics). ## Sources 1. [1910genetics.com](https://www.1910genetics.com/) 2. [1910genetics.com/careers](https://www.1910genetics.com/careers) 3. [greenhouse.io - 1910 Genetics Jobs](https://job-boards.greenhouse.io/1910genetics) 4. [cbinsights.com](https://www.cbinsights.com/company/1910-genetics) 5. [1910genetics.com/team](https://www.1910genetics.com/team) ## Other roles at 1910 - [Computational Theoretical Chemist I](https://feeny.ai/job/computational-theoretical-chemist-i-1910-boston-sdkgw1qv24a3) — Boston, MA - [Computational Theoretical Chemist II](https://feeny.ai/job/computational-theoretical-chemist-ii-1910-boston-1ehmqp7av8kq) — Boston, MA - [Computational Theoretical Chemist III](https://feeny.ai/job/computational-theoretical-chemist-iii-1910-boston-3s3j1qhvyy67) — Boston, MA - [AI Research Scientist I](https://feeny.ai/job/ai-research-scientist-i-1910-boston-6e5tnn82n71k) — Boston, MA - [AI Research Scientist II](https://feeny.ai/job/ai-research-scientist-ii-1910-boston-c8krqw827xs7) — Boston, MA